Journal Article

Incidental gallbladder lymph node metastasis from invasive ductal carcinoma

Journal of Surgical Case Reports, Volume 2026, Issue 11, November 2026, rjag1040, https://doi.org/10.1093/jscr/rjag1040
Published:
10 November 2026
Article history
Received:
28 September 2026
Accepted:
22 October 2026
Published:
10 November 2026

Abstract

Breast cancer metastasis to the gallbladder or its lymphatic drainage is exceedingly rare. We report a woman in her 70s with a remote history of invasive ductal breast carcinoma who underwent elective laparoscopic cholecystectomy for symptomatic cholelithiasis. Histopathology demonstrated chronic cholecystitis and, unexpectedly, metastatic adenocarcinoma within the cystic lymph node of Lund, without involvement of the gallbladder wall or mucosa. Immunohistochemistry showed ER, PR, GATA3, and CK7 positivity with HER2 and CK20 negativity, supporting breast origin and concordance with her previous carcinoma. Subsequent staging identified axillary nodal recurrence without initial visceral or osseous metastases. Endocrine therapy with anastrozole was commenced following multidisciplinary discussion. The patient subsequently developed progressive visceral metastatic disease and died under palliative care. This case highlights the importance of histopathological assessment of cholecystectomy specimens and awareness of atypical metastatic patterns in patients with previous malignancy.

Background

Breast cancer commonly metastasis to the bone, lung, liver, and brain [1, 2]. Involvement of the gallbladder or its lymphatic drainage is exceptionally rare and is usually reported as isolated cases or small series [3–6]. Such disease may be discovered incidentally during cholecystectomy undertaken for presumed benign biliary pathology. The cystic lymph node of Lund lies in the hepatocystic triangle and drains the gallbladder and adjacent biliary structures. Metastatic involvement by an extra-hepatobiliary primary, including breast carcinoma, is highly unusual [7]. This case describes an incidental cystic lymph node metastasis from previous invasive ductal breast carcinoma and highlights the diagnostic importance of histopathology and immunohistochemistry.

Case presentation

A woman in her 70s residing in a nursing home presented with recurrent right upper quadrant pain and nausea. She had a history of left invasive ductal breast carcinoma treated 10 years earlier with breast-conserving surgery, radiotherapy, and 5 years of adjuvant anastrozole. Examination and laboratory tests, including inflammatory markers and liver function tests, were unremarkable. Ultrasound demonstrated multiple gallstones without acute cholecystitis (Fig. 1), while computed tomography (CT) abdomen/pelvis confirmed cholelithiasis without biliary obstruction, mass, or lymphadenopathy (Fig. 2). She underwent uncomplicated elective laparoscopic cholecystectomy for symptomatic cholelithiasis.

For image description, please refer to the figure legend and surrounding text.
Figure 1

Transabdominal ultrasound of the right upper quadrant demonstrating multiple echogenic foci within the gallbladder lumen with posterior acoustic shadowing (arrow), consistent with gallstones. No gallbladder wall thickening or pericholecystic fluid is seen, in keeping with the absence of acute cholecystitis.

For image description, please refer to the figure legend and surrounding text.
Figure 2

Axial portal venous phase contrast-enhanced CT of the abdomen showing multiple hyperdense calculi within the gallbladder lumen (arrow) without wall thickening, pericholecystic fluid, or biliary ductal dilatation, consistent with uncomplicated cholelithiasis.

Investigations

Histopathology showed chronic cholecystitis with cholelithiasis and no malignancy in the gallbladder wall or mucosa. A single cystic lymph node of Lund contained metastatic adenocarcinoma. The tumor was ER-positive, PR-positive, HER2-negative, AE1/3-positive, GATA3-positive, and CK7-positive, with CK20 negativity, supporting breast origin (Figs 3–6). Breast ultrasound and mammography identified a small suspicious lesion adjacent to the previous surgical scar, although targeted biopsy was unsuccessful (Figs 7 and 8). Magnetic resonance imaging (MRI) showed stable postoperative breast changes and a benign-appearing 15 mm subareolar fibroadenoma, but a prominent left axillary lymph node with abnormal morphology was identified (BI-RADS 4A) (Fig. 9A and B). PET-CT demonstrated uptake in the left breast and axilla without visceral or osseous metastases (Fig. 10). CT brain showed no intracranial metastasis. Biopsy of the left axillary node confirmed metastatic invasive ductal carcinoma consistent with the original breast primary. Previous breast slides were reviewed alongside the new specimens and demonstrated histopathological concordance.

For image description, please refer to the figure legend and surrounding text.
Figure 3

Lymph node with infiltrate of atypical epithelioid cells, showing increased nuclear to cytoplasmic ratio, irregular nuclear contours, and indistinct nucleoli (H&E stain, low power).

For image description, please refer to the figure legend and surrounding text.
Figure 4

Immunohistochemistry for CK7 showing strong positivity.

For image description, please refer to the figure legend and surrounding text.
Figure 5

Immunohistochemistry for GATA3 showing strong positivity.

For image description, please refer to the figure legend and surrounding text.
Figure 6

Higher magnification view demonstrating infiltrative ductal architecture of metastatic breast carcinoma (H&E stain, high power).

For image description, please refer to the figure legend and surrounding text.
Figure 7

Left breast ultrasound showing a small irregular, hypoechoic, indistinct lesion at the 6 o’clock position, 1 cm from the nipple, adjacent to scar tissue, measuring 7 × 5 × 6 mm.

For image description, please refer to the figure legend and surrounding text.
Figure 8

Left mammogram showing scattered areas of fibroglandular density (BI-RADS category B composition). Scarring is seen in the upper outer quadrant with a dense macrocalcification. Adjacent to the nipple is an ovoid equal-density mass with stable appearance compared with the previous mammogram. No other discrete suspicious mass or cluster of microcalcifications is identified.

For image description, please refer to the figure legend and surrounding text.
Figure 9

Breast MRI. (A) Axial post-contrast sequence demonstrating stable post-surgical changes and a 15 mm subareolar fibroadenoma within the left breast, without abnormal enhancement to suggest in-breast recurrence. (B) Corresponding slice demonstrating a prominent left axillary lymph node with partial loss of normal fatty hilum and reniform morphology, subsequently confirmed as metastatic on biopsy.

For image description, please refer to the figure legend and surrounding text.
Figure 10

FDG PET-CT scan showing left breast and axillary uptake. No evidence of mediastinal, visceral, or osseous metastasis.

Treatment

The patient underwent laparoscopic cholecystectomy for symptomatic cholelithiasis. Following staging and multidisciplinary review, systemic endocrine therapy with anastrozole was commenced because of hormone receptor positivity and the patient's frailty.

Outcome and follow-up

Postoperative recovery was uncomplicated; she resumed oral intake on postoperative day 2 and was discharged on day 3. She initially remained clinically stable with acceptable tolerance of endocrine therapy, although gradual functional decline occurred in the setting of malignancy and frailty. At ~5 months, disease progression was suspected, with subsequent evidence of liver and lung metastases. Approximately 7 months after diagnosis of the cystic lymph node metastasis, her condition deteriorated and she transitioned to palliative care, where she subsequently died.

Discussion

Breast cancer metastasis to the gallbladder or its lymphatic drainage is exceptionally uncommon and may be detected only after cholecystectomy for apparently benign disease [3–6]. The cystic node of Lund is anatomically associated with the gallbladder and biliary tract, but there is no direct lymphatic pathway from the breast to this node. Hematogenous dissemination is therefore considered a plausible mechanism [7–9]. In our patient, preoperative ultrasound and CT demonstrated uncomplicated cholelithiasis without lymphadenopathy, illustrating the difficulty of identifying microscopic nodal disease radiologically. Histopathological examination therefore provided the diagnosis and triggered further oncological staging.

Immunohistochemistry was central to establishing tumor origin. The metastatic node showed ER, PR, GATA3, and CK7 positivity with HER2 and CK20 negativity, and these findings were concordant with the patient’s previous invasive ductal breast carcinoma [10]. Although unusual gastrointestinal and peritoneal metastases are more frequently associated with invasive lobular carcinoma, invasive ductal carcinoma can also involve atypical sites, including the gallbladder and biliary tract [2, 11, 12].

The incidental nodal metastasis prompted identification of axillary recurrence and allowed systemic treatment to be considered. In a frail patient with hormone receptor-positive metastatic disease, endocrine therapy provided a less intensive treatment option following multidisciplinary discussion [11]. The subsequent development of visceral metastases and death illustrates the aggressive course that can accompany late metastatic recurrence.

This case reinforces the importance of careful histopathological assessment of cholecystectomy specimens, even when surgery is performed for presumed benign disease. It also demonstrates how an unexpected cystic lymph node metastasis can alter staging and lead to further investigation and management of an otherwise clinically occult breast cancer recurrence.

Learning points/take-home messages

  • Metastatic involvement of the gallbladder or its lymphatic drainage from breast carcinoma is exceedingly rare and may be identified incidentally after cholecystectomy.

  • Histopathological examination of cholecystectomy specimens can identify clinically significant unexpected metastatic disease.

  • Immunohistochemistry, interpreted with tumor morphology and clinical history, is important in establishing the origin of metastatic carcinoma.

  • Management of metastatic breast cancer should be individualized according to tumor biology and patient factors.

  • Awareness of atypical metastatic patterns can prompt appropriate staging and influence subsequent oncological management.

Conflicts of interest

None declared.

Funding

None declared.

References

1.

Sung
 
H
,
Ferlay
 
J
,
Siegel
 
RL
 et al.  
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
.
CA Cancer J Clin
 
2021
;
71
:
209
–
49
.

2.

Kennecke
 
H
,
Yerushalmi
 
R
,
Woods
 
R
 et al.  
Metastatic behavior of breast cancer subtypes
.
J Clin Oncol
 
2010
;
28
:
3271
–
7
.

3.

Wang
 
R
,
Zhao
 
F
,
Yan
 
T
 et al.  
Gallbladder metastasis in invasive ductal breast cancer with concurrent gallstones and gallbladder carcinoma: a case report
.
Discov Oncol
 
2022
;
13
:
1007
.

4.

Abdelilah
 
B
,
Mohamed
 
O
,
Yamoul
 
R
 et al.  
Acute cholecystitis as a rare presentation of metastatic breast carcinoma of the gallbladder: case report and review of the literature
.
Pan Afr Med J
 
2014
;
17
:
216
.

5.

Missori
 
G
,
Serra
 
F
,
Prestigiacomo
 
G
 et al.  
Metastatic breast cancer to the gallbladder: a case report
.
F1000Research.
 
2020
;
9
:
343
.

6.

Beaver
 
BL
,
Denning
 
DA
,
Minton
 
JP
.
Metastatic breast carcinoma of the gallbladder
.
J Surg Oncol
 
1986
;
31
:
240
–
2
.

7.

Abrams
 
HL
,
Spiro
 
R
,
Goldstein
 
N
.
Metastases in carcinoma: analysis of 1000 autopsied cases
.
Cancer
 
1950
;
3
:
74
–
85
.

8.

Coletta
 
M
,
Montalti
 
R
,
Pistelli
 
M
 et al.  
Metastatic breast cancer mimicking a hilar cholangiocarcinoma: case report and literature review
.
World J Surg Oncol
 
2014
;
12
:
384
.

9.

Markelov
 
A
,
Taheri
 
H
,
Vunnamadala
 
K
 et al.  
Biliary dyskinesia as a rare presentation of metastatic breast carcinoma of the gallbladder
.
Case Rep Pathol
 
2011
;
2011
:806570.

10.

Sun
 
H
,
Ding
 
Q
,
Sahin
 
AA
.
Immunohistochemistry in the diagnosis and classification of breast tumors
.
Arch Pathol Lab Med
 
2023
;
147
:
1119
–
32
.

11.

Cardoso
 
F
,
Senkus
 
E
,
Costa
 
A
 et al.  
4th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 4)
.
Ann Oncol
 
2018
;
29
:
1634
–
57
.

12.

Di Micco
 
R
,
Santurro
 
L
,
Gasparini
 
P
 et al.  
Rare sites of breast cancer metastasis: a review
.
Transl Cancer Res
 
2019
;
8
:
S518
–
52
.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Gift article access

Please create a link below to share with others. This will provide temporary access to this restricted article.

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

The link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period